Encompass Health Corp (EHC) Shares Bought by Personal Capital Advisors Corp

Personal Capital Advisors Corp increased its stake in shares of Encompass Health Corp (AMEX:EHC) by 2.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 419,523 shares of the company’s stock after buying an additional 11,276 shares during the period. Personal Capital Advisors Corp owned about 0.43% of Encompass Health worth $28,410,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Hancock Holding Co. purchased a new stake in Encompass Health during the first quarter worth about $8,590,000. Principal Financial Group Inc. acquired a new position in Encompass Health during the first quarter worth about $76,632,000. Rothschild Asset Management Inc. acquired a new position in Encompass Health during the first quarter worth about $11,768,000. Northern Trust Corp acquired a new position in Encompass Health during the first quarter worth about $88,764,000. Finally, Ardevora Asset Management LLP acquired a new position in Encompass Health during the second quarter worth about $35,810,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health traded down $0.42, reaching $57.67, during trading on Thursday, Marketbeat Ratings reports. The company had a trading volume of 620,391 shares, compared to its average volume of 618,344. Encompass Health Corp has a 12-month low of $40.86 and a 12-month high of $59.29. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

Encompass Health (AMEX:EHC) last released its earnings results on Wednesday, July 25th. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.16. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.03 billion. Encompass Health’s revenue was up 10.5% on a year-over-year basis. equities research analysts expect that Encompass Health Corp will post 2.72 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 1.87%. This is an increase from Encompass Health’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, September 28th.

In other Encompass Health news, insider Cheryl B. Levy sold 30,982 shares of the business’s stock in a transaction that occurred on Wednesday, May 9th. The shares were sold at an average price of $63.00, for a total transaction of $1,951,866.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Barbara Ann Jacobsmeyer sold 1,798 shares of the business’s stock in a transaction that occurred on Monday, May 14th. The stock was sold at an average price of $62.73, for a total transaction of $112,788.54. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

A number of equities analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 price objective for the company in a research report on Friday, July 27th. Credit Suisse Group boosted their price objective on shares of Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Mizuho reissued a “buy” rating and issued a $82.00 price objective on shares of Encompass Health in a research report on Thursday, July 26th. Finally, SunTrust Banks reissued a “buy” rating and issued a $82.00 price objective on shares of Encompass Health in a research report on Friday, July 20th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $71.10.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: What are CEFs?

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply